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Auditory Brainstem Response (ABR) tests are procedures routinely performed to 
assess auditory function from the peripheral auditory system to the level of the lower 
brainstem. The ABR is used as a neurodiagnostic tool to detect retrocochlear pathologies 
of the auditory system, such as space occupying lesions, tumors, auditory neuropathy, 
and multiple sclerosis that effect the structures located above the level of the cochlea. 
An ABR consists of eliciting and recording waveforms. These waveform 
recordings elicited are compared to normative data to determine normal versus abnormal 
(retrocochlear lesion) responses. Generalized normative data is available for ABR test 
results; however, research states it is important for each audiological clinical facility to 
develop its own set of standardized norms for each piece of testing equipment. 
Normative data has not been developed for the Nicolet Testing System, which is 
currently being used for ABR testing at Louisiana Tech University Speech and Hearing 
Center. 
This study consisted of developing normative data for the Nicolet Testing System. 
In this study, ABR testing was performed on ten adult males and ten adult females. Ail 
participants were between the ages of 18-35 years. All participants also had normal outer 
and middle ear function and normal hearing sensitivity. Normative data was developed 
for the male group, the female group, and both groups combined. Means and standard 
in 
iv 
deviations were determined for waveforms I, III, and V and for the interpeak intervals of 
waveforms I-III, III-V, and I-V. 
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CHAPTER I 
REVIEW OF LITERATURE 
Introduction 
Electroencephalogram (EEG) procedures are currently implemented in the 
medical field to assess and analyze cortical function of individuals with suspected 
dysfunctions and/or abnormalities of the central nervous system (CNS). Through the 
application of electrodes to the scalp, neuronal activity (i.e. electrical potentials or firing 
patterns) are recorded from both the cortex and the brainstem. The minute electrical 
potentials are amplified and displayed as a graph on a computer or oscilloscope and are 
used to evaluate cortical functioning. 
Routinely.used in the field of audiology, EEG procedures are used to evaluate the 
functioning of the auditory system. These procedures are called auditory evoked 
potentials (AEP); that is sound is being used as the stimulus and the electrical responses 
are generated from auditory sources within the brainstem and cortex. During AEP 
procedures, electrodes are placed on the mastoid process (or earlobes) and on the 
forehead. The auditory system is stimulated through as series of clicks or tone bursts and 
AEP responses are plotted as positive and negative fluctuations in microvoltage (mu) as a 
function of time in milliseconds (ms). In recording of an AEP, the stimulus elicits a 
predictable electrical pattern in the form of positive and negative waveforms which occur 
consistently at specific points in time. 
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There are different AEP procedures performed to assess various portions of the 
auditory system. The three main categories of AEP testing implemented are early-latency 
responses, middle-latency responses, and late-latency responses. It is theorized that the 
early evoked responses are generated closer to the peripheral hearing mechanism while 
successive waveforms are believed to occur at the level of the lower and mid-brainstem 
as well as auditory cortex. Therefore, early latency responses typically occur within the 
first 10 ms while the later potentials (i.e., auditory cortex) occur as late as 1000 ms. The 
stimulus and electrode montage differs based on the auditory area being measured. 
Early-latency responses occur within 0.2-10 ms after the stimulus is presented to 
the participant. The most routinely performed early-latency response procedures are the 
w^uvvuCiiiwugiauii j \L-\^KJ<^LLKJ) anu uic j-iuuiLury u i c u n b i t m xvcopuiisc ( n u i v ; 
evaluation. These procedures assess areas of the middle ear, inner ear, and lower auditory 
brainstem function. According to Hall (2006), early-latency responses have the smallest 
magnitude of all the AEP procedures since they assess functioning of regions most distal 
to the cortex. These anatomical structures generating the electrical potential consist of 
few neurons resulting in a much smaller microvoltage change when stimulated. 
Middle-latency responses occur within 10-50 ms after the stimulus is presented to 
the participant. Burkard, Don, and Eggermont (2007) found that middle-latency 
responses are useful for assessing regions of the higher brainstem and auditory cortex, 
including the thalamus and medial geniculate body. The main disadvantage of middle-
latency response testing is responses are skewed if the participant is in a sleeping or in a 
sedated state. This makes testing difficult on infants and/or developmentally delayed 
individuals. 
3 
Late-latency responses, also known as cortical auditory evoked potentials, occur 
within 50-1000 ms after the stimulus is presented to the participant. Hall (2006) found 
that late-latency responses can be implemented to estimate hearing threshold levels, as 
well as an individual's ability to process speech. There are several late-latency responses 
performed, the most routinely performed procedures are the P1-N1-P2 Complex, 
Mismatch negativity, P300, and N400. In general, the later these responses occur, the 
larger the amplitude of the response. 
While later evoked potentials are useful in assessing higher cortical functioning, 
the ABR is the most useful and routinely performed AEP procedures. Therefore, the 
remainder of this discussion will pertain exclusively to the characteristics, parameters, 
and influencing factors pertaining to the ABPv. 
4 
Review of Literature 
The ABR is an objective, early-latency response implemented to assess auditory 
function from the peripheral auditory system to the level of the lower brainstem. 
Ballachanda, Moushegian, and Stillman (1992) defined an ABR as "a series of scalp-
recorded electrical potentials of neural activity generated within the auditory nerve and 
nuclei and tracts of the lower brainstem during the first 10 msec [milliseconds] after a 
click stimulus" (p. 275). 
The ABR typically serves two purposes in clinical audiology. First, the ABR is 
used as a neurodiagnostic tool to detect retrocochlear pathologies of the auditory system, 
such as space occupying lesions, rumors, auditory neuropathy, and multiple sclerosis that 
effect the anatomical structures located above the level of the cochlea. Additionally, ABR 
evaluations are routinely implemented to determine auditory sensitivity. Burkard et al. 
(2007) found that the ABR is a useful test for estimating hearing levels in individuals 
who cannot complete a traditional, behavioral audiological evaluation (e.g., infants, small 
children, and developmentally delayed). The focus and purpose of this study is limited to 
the examination of the neurodiagnostic ABR. When ABR appears in the remaining 
portion of this paper the author is referring to a neurodiagnostic ABR. 
According to Burkard et al. (2007), an ABR consists of seven recognizable 
waveforms, which are labeled with roman numerals I-VII. Clinically, only waveforms I-
V are identified and analyzed. Waveforms II and IV are often variable; therefore, for 
clinical numoses, an A.BR is analyzed in terms of waveforms I, III, and V. The waveform 
recordings elicited during an ABR are used to determine normal versus abnormal 
(retrocochlear lesion) responses. Figure 1 provides an example of an ABR recording. 
im f 
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Figure 1 Example of ABR Recording. 
Song, Banai, Russo, and Kraus (2006) stated the ABR "is generated by 
synchronous firing of structures along the ascending auditory pathway, which include the 
auditoiy nerve, cochlear nuclei, superior olivary nuclei, lateral lemnisci, and inferior 
colliculi" (p. 233). The exact anatomical structures generating the peaks of the ABR 
responses are still debated; however, many researchers have agreed upon proposed 
possible loci (ASHA Working Group, 2008; Bhattacharyya & Scott, 2006; Hall, 2006; 
Hood, 1998b). Waveform I arises from the distal portion of the eighth nerve (where the 
fiber tracts leave the cochlea), while waveform II arises from the proximal portion of the 
eighth nerve (where the fiber tracts enter the lower brainstem). The exact location or 
structures that generate waveforms III-V is not as conclusive as waveforms I and II, and 
several structures may be involved. Waveform III is believed to arise from the cochlear 
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nucleus and pons regions on the ipsilateral side (same side the stimulus is presented) of 
stimulation. Waveform IV is thought to arise from the superior olivary complex and 
surrounding fiber tracts on both the ipsilateral and contralateral side (opposite side the 
stimulus is presented) of stimulation. Waveform V is believed to be generated from 
neurons in the lateral lemniscus, inferior colliculus, and the fiber tracts connecting them 
on the contralateral side of stimulation. 
Hood (1998b) also agreed that the exact neural generators of the later waveforms 
are not conclusive. She stated 
Recordings from the cochlear nucleus correspond with the surface-recorded Wave 
III, suggesting that Wave III is generated mainly by neurons in the cochlear 
nucleus. The neural generators of Wave IV are uncertain, although third-order 
neurons in the superior olivary complex are most likely involved; other 
contributors may include the cochlear nucleus and the nucleus of the lateral 
lemniscus. Wave V may be related to activity in the lateral lemniscus and inferior 
colliculus, but it should be emphasized that peaks IV, V, VI, and VII of the ABR 
are complex, with more that one anatomical structure contributing to each peak 
and each structure contributing to more than one peak. (p. 15) 
In summary, research is conclusive that the eighth cranial nerve is the neural 
generator of waveforms I and II of the ABR, with the distal portion contributing more to 
waveform I and the proximal portion contributing more to waveform II. The exact neural 
venerators of waveforms III-V is inconclusive and it is believed that several structures in 
the brainstem contribute to each of these waveforms. Researchers such as Hall (2006) 
have agreed that the fiber tracts surrounding the cochlear nucleus significantly contribute 
1 
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to waveform III, while the superior olivary complex and its surrounding structures are the 
primary generators of waveform IV. Researchers have also agreed that there may be 
several structures contributing to waveform V with the lateral lemniscus and inferior 
colliculus regions being the primary generators. 
Testing Parameters 
Certain parameters are used to evaluate ABR waveforms to determine if the 
evoked responses are within normal limits. The two main parameters analyzed are 
latency and amplitude. In neurodiagnostic testing, waveform latency is predominately 
used to determine "normal" versus "abnormal" results. The rationale for its widespread 
use is due to the reliability and consistency of responses. Amplitude, which contributing 
to neurodiagnostic testing, is highly variable from participant to participant. 
Latency 
Latency is the time taken for the responses to occur following a stimulus 
presentation, and is measured in ms. Waveform responses are labeled by looking for 
positive microvoltage peaks at specific points in time. Burkard et al. (2007) found that 
peak latencies are determined by how the stimulus travels through the structures of the 
ear and the brainstem. If there is a clear pathway from the outer ear through the 
brainstem, latency values should occur within a designated time period. If any of the 
above structures are disordered, a prolongation of latency waveform can occur and 
occasionally waveforms can disappear all together. 
Latency values are analyzed by calculating the absolute latency values, interpeak 
latency values, and interaural latency difference. The absolute latency is the time taken 
for each waveform to occur after a stimulus is presented to the ear. Hall (2006) found that 
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when using click stimuli at high intensity levels (70-90 dBnHL), waveform I occurs at 
approximately 1.5 ras after the stimulus is presented to the ear. The following waveforms 
(i.e., II, III, IV, and V) occur at approximately 1.0 ms intervals of waveform I, so 2.5 ms 
for wave II, 3.5 ms for wave III, 4.5 ms for wave IV, and 5.5 ms for wave V. 
The absolute latency is also affected by how the signal travels from the basal 
portion to the apical portion of the cochlea. Signals traveling through the apical portion of 
the cochlea result in increased latency compared to those traveling through the basilar 
portion. Low frequency sounds travel through the apical portion of the cochlea, while 
high frequency sounds travel through the basilar end; resulting in increased latency for 
low frequency stimuli compared to higher frequency stimuli. 
The interpeak latency (IPL) value is the time difference in absolute latency 
between waveforms. The I-III, III-V, and I-V IPLs are calculated when all waveforms are 
labeled in terms of absolute latency. These IPLs are then compared to normative values 
to determine if they occur within normal limits. The IPL should be approximately 2.0 ms 
for waveforms I-III, 2.0 ms for waveforms III-V, and 4.0 ms for waveforms I-V. 
According to Hood (1998b), the IPL should not be more than ±0.4 ms from the norm to 
be considered normal. 
The waves I-III interval represents synchronous activity in the eighth nerve and 
lower brainstem, whereas the III-V interval may reflect activity primarily within the 
brainstem. The I-V interval is considered a representation of overall activity from the 
eighth nerve and the nuclei and tracts of the brainstem responsive to auditory stimuli. 
(Hood, 1998b, p. 17) 
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The interaural latency difference (ILD) is the absolute latency difference of 
waveform V between the ipsilateral recordings for each ear. For example, if the absolute 
latency of wave V is 5.5 ms for the right ear and the absolute latency of wave V for the 
left ear is 5.7 ms, the ILD is 0.2 ms. According to Hood (1998b) the interaural latency 
difference is a useful tool for diagnosing retrocochlear lesions of the auditory system. The 
ILD should not differ by more than 0.4 ms if the participant has similar hearing between 
ears; however, caution must be taken when an asymmetrical hearing loss is present. 
Waveform Amplitude 
The amplitude is the magnitude or power of the response and is measured in 
microvolts (uV). Due to the variability among participants, less emphasis is placed on the 
amplitude values of the waveforms compared to the latency values. Burkard et al. (2007) 
stated "the amplitudes of ABR peaks reflect the number of neural elements that are 
activated synchronously. Thus, both the number of elements and the degree of synchrony 
affect the amplitudes" (p. 233). Burkard and fellow researchers (2007) found that the 
absolute amplitude values are variable among participants even when the noise in the 
testing environment is controlled. Additionally, Katz (2002) noted that elderly individuals 
showed a decrease in waveform, amplitude when compared to young and middle-aged 
adults. 
While amplitude is used to a lesser extent than latency when evaluating 
neurodiagnostic ABRs, there are always exceptions. The only amplitude measurement in 
neurodiagnostic ABR testing is the V/I amplitude ratio. The V/I amplitude ratio is the 
difference in amplitude between waveforms V and I for each ear. According to Hall 
(2006), the V7I amplitude ratio is calculated by determining the absolute peak amplitude 
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point on each waveform from a baseline or reference point and comparing the two. The 
amplitude of waveform V should always be greater than waveform I by a ratio of at least 
luV. If the ratio falls below 0.5uV, this is an indication of a possible retrocochlear 
lesion. 
Factors Affecting ABR Results 
There are a variety of factors that can affect and distort ABR waveforms, 
including participant factors, stimulus factors, recording factors, and waveform labeling. 
Testing results are also affected by the type of electrodes used and where they are placed 
on the participant. All of these factors must be controlled to ensure valid and reliable 
electrophysiological responses are obtained. 
Participant Factors 
For accurate and valid ABR results, the participant must be in a relaxed state for 
optimal testing to be completed. This is important because any type of participant 
movement may skew the test results for that particular trial or run. Patient movement 
results in muscle contraction, which generates an electrical (neural) signal. When this 
occurs it is likely that the scalp electrodes can detect this neural activity and therefore the 
auditory response may be obscured in "noise". This type of noise is called myogenic 
noise and must be controlled when conducting testing. Typically this can be achieved by 
inviting the participant to relax and even sleep if possible. It must be clearly conveyed to 
the participant what the test involves and what is expected of them during testing. 
T^a-rt 1 p i r v q n f Tor'trMrc1 r*on a lcr^ r\£± rr\v\t-rr\ 11 c±A r\\r r > r \ n n n p t i t i r r f o c t i - n a -« n a /-n-jt^f r l o f i ^ 
comfortable environment where the participant can relax free of outside noises or 
distractions. 
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There are some participant factors that cannot be controlled or altered, and 
therefore must be accounted for when conducting testing. This includes the patient's age, 
gender, body temperature, and hearing loss. In addition, certain medications can also 
affect latency and amplitude values; therefore must be avoided prior to testing. 
Age. ~ . 
Infants and elderly individuals show increased latency values compared to young 
and middle-aged adults. According to Hood (1998b), infant ABR recordings show 
increased latency values until the child reaches approximately 12-18 months of age. The 
delays in latencies reflect the maturational development of the central auditory nervous 
system of infants from birth through 18 months of age. Hood (1998b) found that 
waveform I of infants often show slight delays, while waveform V typically shows the 
longest delay compared to adult recordings. The increase in wave V latency of infants 
results in an increased 1-V interpeak interval latency value (approximately 5.0 ms) when 
compared to the I-V interpeak latencies in adults. She stated that "this prolongation may 
be related to cochlear maturation, neuronal maturation, reduced efficiency in external 
and/or middle ear sound transmission, and occasionally collapsing ear canals" (p. 61). 
Advances in age have also shown effects on latency and amplitude values of ABR 
recordings. According to Hall (2006), individuals above 60 years of age show increased 
latency values for the later waveforms (waves III-VII) and decreased amplitude for all 
waveforms compared to middle-aged adults. This increase in latency of waveforms III-
VII results in increased interpeak latency values for older adults. There is speculation 
regarding the differences in ABR results for middle aged adults compared to the older 
adult population. It has been proposed that these differences are due to deterioration of 
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the auditory brainstem structures of older adults, resulting in effects to the later 
waveforms. 
Gender. 
ABR recordings are also different for males compared to females. According to 
Burkard et al. (2007), females show shorter absolute latency values, smaller interpeak 
interval values, and increased waveform amplitude compared to males. These differences 
between sexes have been attributed to the average head size differences between males 
and females. On average, males have larger head sizes, larger cochleas, and longer fiber 
tracts connecting the cochlea to the central auditory cortex than females do. These factors 
cause the electrical potentials generated by the auditory system to travel further to the 
recording electrodes located on the scalp. This increased distance results in increased 
latency values and decreased, amplitude values for males when compared to females. 
Body Temperature. 
Differences in participant body temperature can also skew results. Katz (2002) 
found that a decrease in participant body temperature leads to a decrease in waveform 
amplitude and an increase in waveform latency. Decreased body temperature can be the 
result of drug and alcohol use or hypothermia. 
Hearing Loss. 
Hearing loss is another factor that must be accounted for that can affect ABR 
results. The effect the hearing loss has on test results depends on the type, severity, and 
configuration of the loss. Sininger (1992) proposed that "a hearing loss can degrade 
waveform morphology for the earlier waveforms, increase latency, and decrease 
amplitude. If a hearing loss is present, correction factors must be used" (p. 16). Hood 
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(1998b) found that for individuals with auditory thresholds at or above 50 dB HL from 
2000-4000 Hertz (Hz), waveform latency values and waveform morphology may be 
affected. The affects of the hearing loss may result in an absent or delayed waveform I, 
delayed waveform V, and/or poor overall waveform morphology. The more severe the 
hearing loss in the 2000-4000 Hz range, the greater the chance it affects^  ABR results. 
Hall (2006) found that when testing at high intensity levels (>80 dBnHL), a hearing loss 
does not effect ABR results until auditory thresholds reach at least 50-60 dBHL from 
1000-40000 Hz. 
The interpeak interval values may also be affected by sensorineural hearing loss, 
According to Hood (1998b), individuals with very steep high frequency hearing losses 
(i.e., normal hearing in the low frequencies with a steep decrease in hearing sensitivity in 
the mid to high frequencies) have shown delayed latency values for waveform I and 
minimal delays or normal latency values of waveform V. This delay of waveform I 
results in a reduced I-V IP I value which may be falsely identified as falling below the 
normal range. Hall (2006) found that ABR interpeak waveforms are less affected by a flat 
hearing loss compared to a steep sloping high frequency hearing loss, which he attributed 
to basilar membrane functioning. That is, a flat hearing loss impacts all portions of the 
basilar membrane, while a high frequency hearing loss only affects the basal portion of 
the basilar membrane. 
Conductive hearing loss can also impact ABR. waveforms. According to Hall 
(2006), if a conductive hearing loss is present, all ABR waveforms show increased 
latency values. Absolute latencies shift in time due to the presence of the conductive 
pathology. Since all waveforms show increased latencies, the interpeak waveform 
14 
latencies should not be affected. Normal interpeak waveform values help differentiate a 
conductive hearing loss from a retrocochlear pathology. 
Medications. , 
Certain medications have been shown to affect-latency values of ABR recordings. 
Hood (1998b) stated 
Abnormal ABR's have been reported in conjunction with medications such as 
phenytoin, lidocaine, and diazepam. Also, carbamazepine (CBZ) monotherapy in 
epileptic patients has been reported to result in prolongation of the peak latencies 
of Waves I, III, and V and prolongation of Waves I-III and I-V intervals. 
Documentation of medications should assist in appropriate interpretation of test 
results, (p. 62) 
Stimulus Factors 
The type of stimulus (e.g., tone pips, clicks) being presented to the participant 
determines the specific response that is elicited and assesses different areas of the 
auditory system. There are several stimulus factors that need to be considered prior to 
testing, including the stimulus type, rate, phase, and presentation level used. There are 
also different types of transducers that can be used during testing, which affects the 
stimulus. 
Stimulus Type. 
The two most common types of stimuli used in ABR testing are clicks and tone 
hnr^tQ' hciwe.\/pr rlirkz arp trip QtimnliK: r\f rhnirp for npurnrht i rmnct ic A RT? fpctincr 
According to Hall (2006), the use of click stimuli primarily tests the 1000-4000 Hz 
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region of the cochlea and auditory system, which does not account for the low frequency 
regions. The ASHA Working Group (2008) stated 
Clicks are the most commonly used stimuli for eliciting the ABR. The abrupt 
onset and broad spectrum, of a click result in synchronous excitation of a broad 
population of neurons. The click is usually the most effective stimulus and can 
provide high frequency information, (p. 15) 
In other words, the abrupt click stimulus promotes the greatest amount of neural 
activity within the lower brainstem. This increase in neural activity provides the most 
robust waveforms with the best morphology. This is the reason why neurodiagnostic 
ABR evaluations are typically conducted using a click stimulus. For neurodiagnostic 
testing, the stimulus should be presented at high intensity levels so all waveforms can be 
identified. 
Stimulus Level. 
The stimulus level is the intensity of the stimulus presented to the participant. As 
a general rule, when the intensity of the stimulus is increased above a person's auditory 
threshold, the amplitude of the ABR waveforms increases and the latency decreases. For 
neurodiagnostic testing it is optimal to perform testing at high intensity levels (e.g., 70-
100 dBnHL). At this high intensity level, neural synchrony of the VIII nerve and lower 
brainstem is optimized and results in robust responses. The increased amplitude results in 
better morphology and therefore, makes the identification of absolute and interpeak 
latencies much easier to identify. Hall (2006) found that waveforms I-V are most easily 
recognizable and distinguishable at levels well above auditory thresholds. ' 
16 
Stimulus Rate. 
The stimulus rate refers to the number of times the stimulus is presented to the 
participant per second. As the stimulus rate is.increased, waveform amplitude values are 
reduced and latency values are increased; as the rate is decreased, amplitude values 
increase and the latency values decrease. Burkard et al. (2007) suggested that increasing 
the stimulus rate increases the latency of waveform V; however, it has shown little effect 
on waveform I, causing the interpeak interval to increase with the use of high stimulus 
rates. 
According to Sininger and Don (1989), implementing high click rates during 
ABR testing reduces the amount of time taken for testing to be completed. They also 
found that increases in the click rate above 30 clicks per second results in neural 
adaptation of the auditory system, which may lead to reduced waveform amplitude and 
morphology. Implementing a high click rate makes it more difficult to accurately identify 
waveforms. The ASHA working group (2008) found that "faster rates prolong the 
latencies of all the waves progressively, so that Wave I is delayed approximately 0.1 ms 
and Wave V is delayed approximately 0.3 ms between rates of 10 and 50/second. High 
rates also decrease the amplitudes of waves prior to Wave V" (p. 17). 
Hall (2006) found that implementing faster presentation rates results in reduced 
testing time, while slower rates result in more robust responses. He recommends using an 
odd number to reduce the chances of electrical interference. Research has shown that 
ratgc .^ bove 20 cii^kc/c'='cnpr' have ehr*wn in^r/3CicAc iri v/Qv3^?orrri ^^nc^7 and decreases m 
amplitude. The stimulus rate most effective differs for neurodiagnostic testing compared 
to threshold testing. 
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According to the ASHA Working Group (2008) 
Low rates are advisable when a full complement of waves is necessary, such as in 
the case of otoneurolosic evaluations. For other Durnoses, such as threshold 
testing, rates of 25-40/second are acceptable because the amplitude of Wave V is 
minimally reduced. This improves the efficiency of ABR measurements because 
more averages can be taken in the same period of time. (p. 17) 
According to Hall (2006), testing with high stimulus rates after waveforms have 
been properly identified using low rates, is a useful diagnostic tool for identifying 
abnormalities to the CNS. Presenting stimuli at fast rates stresses the auditory system and 
can result in abnormally prolonged or absent waveforms if certain abnormities exist. This 
evaluation is often called a rate study and is used as an additional tool to evaluate the 
lower auditory brainstem for retrocochlear disorders. Prior to performing a rate study, ail 
waveforms must be clearly defined and distinguishable. When performing a rate study, 
only wave V is trying to be identified. Hall (2006) stated 
Abnormal latency shifts or disappearance of later waves at very rapid stimulus 
rates have been reported in various types of peripheral and CNS pathology, 
including eighth-nerve tumors, epidermoid tumor of the fourth ventricle, head 
injury, hypoxia, mixed CNS diseases, and multiple sclerosi. (p. 184) 
i nereiore, a rate stuuy is often conducteu alter an AJ3R is coiiecteu at a lower 
stimulus rate and the absolute and interpeak latencies are evaluated against normative 
values. According to Hall (2006), as a general rule, the latency of wave V should increase 
by 0.1 ras for every increase of 10 clicks per second of the stimulus. As an example, 
wave V collected at a slow rate of 19.1 clicks per second yielded a wave V absolute 
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latency of 5.5 ms. If the rate is then increased from 19.1 to 89.1 clicks per second, wave 
V should increase to a latency of no longer than 6.2 ms. A rate study wave V shift of 
more than this (0.7 ms) would be considered abnormal and a positive finding foi a 
retrocochlear pathology. 
Stimulus Phase. 
The stimulus phase or polarity refers to the initial deflection of the transducer 
when the stimulus is presented. There are three stimulus polarities used to perform ABR 
testing: rarefaction, condensation, and alternating. The stimulus is in the negative phase 
when using a rarefaction polarity, the stimulus is in the positive phase when using a 
condensation polarity, and the stimulus alternates between rarefaction and condensation 
when using an alternating phase. 
The stimulus phase affects the morphology, amplitude, and latency of the 
waveforms. According to Fowler (1992), when using intensity levels well above hearing. 
thresholds, rarefaction stimuli have been shown to increase neural activity; while near 
thresholds, the effects of the stimulus phase are minimal. At high-intensity levels, 
waveforms I, III, and V occur at shorter latency values for rarefaction stimuli then they 
do for condensation stimuli. The interpeak interval remains constant regardless the 
stimulus phase used, since the latency between waveforms remains unchanged. 
Hood (1998b) found that a rarefaction stimulus produces an outward movement 
of the transducer, which leads to an initial outward movement to the structures of the 
middle ear and an upward movement to the basilar membrane in the inner ear, resulting 
in hair cell depolarization. A condensation stimulus produces an inward movement of the 
transducer prior to an outward movement, which results in increased time taken for hair 
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ceil depolarization to occur. Therefore, the early components of the ABR (waveforms I 
and II) result in reduced latency and increased amplitude values when implementing a 
rarefaction stimulus. This means that using a rarefaction stimulus provides the greatest 
chance for accurately identifying and labeling waveform I. According to Hall (2006), 
when using click stimuli, a rarefaction phase results in a reduced latency and increased 
amplitude for waveform I. The reduced latency is consistent with the cochlear mechanics 
that take place when implementing a rarefaction click compared to a condensation click. 
Hall (2006) stated, "Perhaps the most consistent polarity-related ABR finding is shorter 
latency for wave I (on the average about 0.07 ms) for rarefaction clicks" (p. 185). 
Research regarding the effects of the stimulus phase is not as conclusive for the 
later waveforms (wave III-V) as it is for the early waveforms. Hood (1998b) found that 
the amplitude of waveform V is greater when using a condensation stimulus compared to 
a rarefaction stimulus. She reports no differences in wave V latency regardless of the 
polarity implemented. Hall (2006) noted that previous research conducted to determine 
the effects of stimulus polarity of waveforms III and V is inconsistent. These 
inconsistencies may be due to experimental differences in research methodology 
regarding the participants tested and the stimulus rates and levels implemented during 
testing. Hall (2006) stated that "there is no consensus on which of the ABR wave 
components are most affected or most consistently affected. That is, selected waves, such 
as waves I and V, may have shorter latencies for rarefaction clicks, whereas another 
wave, such as wave III, may have shorter latency for condensation clicks" (p. 185). 
According to Hood (1998b), the use of an alternating polarity can be implemented 
to reduce stimulus artifact. It is designed to reduce artifact by canceling responses that are 
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out of phase; however, when used during air conduction testing, this alters the ABR 
response. Hood (1998b) stated that "the introduction of insert earphones with an inherent 
delay line of 0.9 ms has served to reduce the interference of stimulus artifact with the 
response. Therefore, the only time that alternating-polarity stimuli are recommended is 
when using a bone-conduction transducer" (p. 53). 
Transducers. 
A transducer is a device used to transfer energy from one form to another. There 
are several different transducers that can be used for ABR testing, including supra-aural 
ear phones, insert earphones, and bone conduction transducers. The type of transducer 
used determines or shapes the stimulus, referred to as the stimulus spectrum or to the 
frequency response of the stimulus as it goes through the transducer to the ear. It is ideal 
for the stimulus spectrum to have a flat frequency response (i.e., intensity levels are equal 
across ail frequencies). If frequency alterations occur in the spectrum, those frequency 
regions with increased amplitude may provide more stimulation than intended anu tnose 
regions with decreased amplitude may not provide enough stimulation. Thus, the 
stimulus being presented to the participant may differ from the intended stimulus. 
According to Laws, Roller, and Perry (1993), supra-aural earphones were the 
most common transducer used in ABR testing until the development of insert earphones. 
They found that the use of insert earphones decreases the need for contralateral masking 
because inserts increase the interaural attenuation by approximately 10-12 dB over supra-
aural headphones during ABR testing. Laws .and fellow researchers (1993) stated that 
insert earphones provide certain advantages, "such as ambient noise exclusion, less 
likelihood of recording electrical artifact, and increased interaural attenuation" (p. 60). 
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Another advantage of using insert earphones is the prevention of collapsing ear canals. 
The use of supra-aural headphones can push down on the tragus portion of the outer ear 
creating a closed or collapsed ear canal, resulting in an artificial conductive hearing loss 
and invalid ABR responses. The possibility of a collapsing ear canal is eliminated when 
using insert earphones, since there is no pressure being forced on the tragus. 
Noise 
In auditory evoked potential testing, noise refers to any electrical potential that is 
not part of the auditory response to stimulus. In other words, any electrical potential that 
is measured by the electrodes that is not part of the auditory response is considered noise. 
Noise can be the result of electrical interference from computers and lights, or muscle 
artifact or movement from the participant themselves. The goal of the test administrator is 
to reduce the noise present improving the signal-to-noise ratio (SNR). The higher the 
SNR, the more likely the elicited responses are true auditory evoked potentials and not 
responses from noise sources. 
Recording Factors 
Recording factors .are techniques employed to prevent unwanted noise from 
skewing true electrophysiological responses. They are used to help determine what 
responses are the results of noise and what responses are truly evoked. The recording 
factors used include filter settings, signal averaging, artifact rejection, and the number of 
presentations performed. 
Filters, 
The use of filtering is an effective technique to improve the SNR. Filters are 
designed to allow electrical, signals with certain frequency parameters to pass through 
unaffected while rejecting all other signals. ABR testing typically involves the use of a 
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band-pass filter, which consists of a low-pass filter and a high-pass filter. The filter 
settings should be set to reduce the effects of low and high frequency noise while 
allowing the response to pass through. Burkard et al. (2007) found that "for the click-
evoked ABR, the high-pass cutoff most often used is 100 Hz, and the most common low-
pass cutoff is 3000 Hz" (p. 231). 
\icrvinl Avpvncrivio 
Signal averaging is a technique used to differentiate true electrophysiological 
responses from noise. This is automatically employed through the amplifier of most ABR 
testing software. Signal averaging consists of sampling the voltage of the response from 
many different points to determine if the response is the result of noise or if it is a true 
elicited response. Each time the stimulus is presented, the response is analyzed at each 
point and an average voltage level is determined for each point. Hall (2006) proposed that 
responses that are the result of noise appear randomly, while electrophysiological 
responses occur consistently. The concept behind signal averaging is that if noise is 
measured during the ABR recording it is random in nature. If sufficient recordings are 
made and averaged together the random noise is canceled from the electrophysiological 
response. This process reduces the random noise while enhancing the consistent auditory 
response, thus increasing the SNR or the ABR. According to Hall (2006), "conventional 
(mean) averaging is invariably utilized clinical to extract and enhance auditory evoked 
responses embedded within background neurogenic and neurologic activity" (p. 207). 
Artifact Rejection. 
Artifact rejection is another clinically useful technique that is also automatically 
performed by the ABR amplifier to prevent unwanted responses from skewing test 
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results. According to Hall (2006), artifact rejection consists of sampling the voltage of 
each response. If the voltage of the response exceeds a certain sensitivity limit set on the 
amplifier, the response is rejected and is not sent to the signal averaging device. The 
primary purpose of artifact rejection is to prevent these responses from being averaged 
into the response. Responses with extremely large voltages are not auditory responses 
and often occur due to muscle activity as a result of movement during testing. If these 
large, non-auditory responses are sent to the signal average process, the ABR 
morphology suffers and the SNR decreases (Sanchez & Gans, 2006). In other words, 
artifact rejection ".. .evaluates the amplitude of the incoming noise from the electrodes 
for individual sweeps. If the noise exceeds a predetermined microvolt level, the sweep is 
rejected from the computer memory and not included in the averaging process" (Sanchez 
& Gans, 2009, 154-155). 
Presentations. 
The number of presentations or sweeps performed refers to how many stimulus 
presentations are performed for each obtained response. The number of sweeps 
performed is determined by the test administrator prior to testing and can range from 100 
to 2500 sweeps. The number needed to ensure true elicited responses is variable among 
participants and presentations. According to Hall (2006), "the number of sweeps required 
in ABR measurement is highly dependent on the signal-to-noise ratio, on both the 
magnitude of ABR. components and the amount of measurement noise arising from 
diverse sources" (p. 211). In clinical evaluations, when all waveforms can be accurately-
identified, the presentations/averaging can be stopped. 
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Electrodes. 
The type of electrodes used and the manner in which they are placed affects the 
recordings of the elicited response. The most common electrode array involves an 
inverting and non-inverting electrode montage. This array consists of inverting electrodes 
on the right (A2) and left mastoids or earlobes (Al), a non-inverting electrode on the high 
forehead (Fz), and a ground electrode on the lower forehead (FPz). Hall (2006) stated the 
following objectives of electrode placement: 
(1) consistent placement among subjects, (2) anatomically accurate placement, (3) 
low inter-electrode impedance (less than 5000 ohms), (4) balanced inter-electrode 
impedance (difference between electrodes less than 2000 ohms), (5) secure and 
consistent attachment throughout the test session, and (6) minimal discomfort and 
no risk to the subject, (p. 80) 
Waveform Labeling. 
The absolute latencies and the IPL values are determined by where the waveforms 
are labeled on the response. This is a subjective measurement made by the test analyzer 
that determines normal versus abnormal responses, so the analyzer must be accurate and 
consistent. Where the waveforms are labeled depends on the overall morphology, or 
appearance of the responses. If the morphology is poor, the waveforms may be difficult 
to label even if the latency and amplitude appear normal. 
There are two classification systems routinely administered to determine the 
precise latency values of the waveforms, the peak method and the shoulder method. 
When using the peak method, the waveform is labeled where the highest voltage point 
(peak) occurs on the selected waveform. When using the shoulder method, the final point 
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on the waveform before the response amplitude begins to decrease is labeled as the 
precise latency. Amplitude values are determined by calculating the voltage difference 
between the peak of the waveform and the following trough, or by calculating the voltage 
of the peak with a baseline point (Hall, 1992). 
The shoulder method is used when multiple waveforms are fused together. This 
occurs most onen with waveforms iV and v wnicti can oe iused togetner resulting in 
what is called a wave IV/V complex. The wave IV/V complex looks like one large 
waveform. If the peak method is used in this situation, the examiner may actually be 
mislabeling the exact location of wave V, resulting in abnormal results. Therefore, the 
shoulder method is often used to overcome the wave IV/V complex. 
Hood (1998b) found that waveform I can difficult to identify in many 
participants, especially if high frequency hearing loss is present. Waveform I may be 
absent or reduced even if waveforms III and V are present at robust amplitudes and 
normal latency values. The inability to identify waveform I results in the inability to 
determine the I-III and I-V interpeak interval values (IP I). The IP I values are important in 
diagnosing cochlear versus retrocochlear site of lesion, therefore it is important to 
correctly identify wave I. If waveform I is reduced or absent certain measures can be 
taken to increase the waveforms amplitude and morphology. For instance, Hood (1998b) 
recommended increasing stimulus intensity, using rarefaction clicks, and decreasing click 
presentation rate. 
Clinical Applications 
The development of ABR testing has allowed for a routine method of 
differentiating between cochlear and retrocochlear disorders of the auditory system. 
Neurodiagnostic ABRs are designed specifically to diagnose dysfunction and/or lesions 
of the eighth cranial nerve and/or areas of the lower brainstem. This includes space 
occupying lesions, such as neoplasms of the cerebellopontine angle (CPA), vestibular 
schwannomas, neurofibromas, and meningiomas. The use of ABR testing has also been 
implemented to identify and diagnose auditory neuropathy/dys-synchrony. 
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to Hall (2006), common symptoms that determine if an individual should be referred for 
an ABR include an asymmetrical or unilateral sensorineural hearing loss, poor word 
recognition scores (<30%) compared to pure tone auditory thresholds, episodes of 
vertigo, aural fullness, and/or unilateral tinnitus. Bhattacharyya and Scott (2006) 
suggested that if an ABR yields abnormal results, a magnetic resonance imaging (MRI) 
evaluation should be administered. The average cost of an MRI is five times the cost of 
an ABR, so the use of an ABR as an initial diagnostic tool is a cost efficient measure. 
Vestibular Schwannoma 
According to Hall (2006) vestibular schwannomas are benign tumors that arise 
from the Schwann cells that cover the eighth cranial nerve. These are usually unilateral 
and are most frequent among middle-aged adults. The incidence of a vestibular 
schwannoma is around 9:100,000 and are twice as prevalent among females. Hall (2006) 
suggested 
The vestibular schwannoma typically grows to displace, deform, and/or stretch 
the normal auditory nerve fibers, which may eventually be compressed into a thin 
ribbon. In addition to compressive effects of the eighth-nerve tumor, symptoms 
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may be due to compromise of the blood supply to the nerve or inner ear or to 
interruption of cochlear fluid flow. (p. 372) 
Neurofibromas are genetic disorders which also arise from the Schwann cells. 
These are most often effect the eighth cranial nerve. There are two different forms of 
neurofibromas, neurofibromatosis 1 (NF 1) and neurofibromas 2 (NF 2). Hall (2006) 
found that NF I is much more prevalent than NF 2 and typically appears earlier in life 
than NF 2. NF 1 is a peripheral abnormality and is usually bilateral, while NF 2 is a 
central abnormality, meaning it occurs higher in the brainstem. The most common 
symptoms of neurofibromas are hearing loss and cafe au lait spots (skin abnormalities). 
Hall (2006) classified meningiomas as tumors arising from meningothelial 
arachnoid cells. Meningiomas are also more prevalent among females than males. The 
symptoms present depend on the location and size of the lesion. Meningiomas typically 
appear later in adulthood and may have no effect on auditory functioning. 
Hood (1998b) proposed that the presence of a retrocochlear disorder, such as an 
acoustic neuroma, can affect the ABR waveforms in several different ways. It may result 
in prolongation of the absolute latencies of the waveforms, prolongation of the interpeak 
interval latency values, absent waveforms, or degraded morphology of the waveforms. 
The result the lesion has on the ABR depends on the size of the lesion and where it 
occurs in the auditory system. The most prevalent patterns for identifying 
cerebellopontine angle tumors are absent waveforms III and V, or a delayed wave I-V 
interpeak interval latency value. Abnormal wave V/I amplitude ratios have also been 
identified in individuals with confirmed tumors. Hood (1998b) found that in a study of 61 
patients with eighth nerve or brainstem tumors, 30% of the patients had no recognizable 
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waveforms, 44% showed some absent waveforms, and 26% of the patient's showed 
abnormal waveform latency values. 
Auditory Neuropathy 
According to Hood (1998a), auditory neuropathy is a condition that affects 
individuals of all ages. These individuals show normal outer hair cell functioning but 
abnormal neural transmission of sound from the inner ear system through the auditory 
brainstem. Individuals with auditory neuropathy may have normal sound awareness 
abilities, but difficulties discriminating speech. 
Hood (1998a) found that audiological testing typically results in normal 
otoacoustic emissions and absent ABR responses. Behavioral testing has shown mixed 
results, with pure tone results ranging from normal hearing to a profound sensorineural 
hearing loss. Speech testing is also variable, but is usually very poor especially in noisy 
environments. 
i ne exact sue oi iesion causing me auoitory neuropathy nss not Deen clearly 
identified. Hood (1998a) proposed that there are several possible sites of lesion, including 
the inner hair cells and/or the synapses occurring within the inner hair cells, the VIII 
nerve fibers, or the tectorial membrane. An auditory neuropathy may also affect the 
afferent and/or the efferent pathways. 
According to Hood (1998a), the ABR is one of the most useful tools for 
diagnosing auditory neuropathy. If a neuropathy exists, the ABR waveforms are absent or 
severely abnormal; however, a clear cochlear microphonic is present with a reversal of 
stimulus polarity at high levels. Diagnosing auditory neuropathy as soon as possible can 
lead to appropriate intervention. 
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Sensitivity 
The sensitivity of an ABR refers to its ability to detect abnormalities of the 
auditory system. For space occupying lesions, the size of the lesion is proportionate to the 
sensitivity of the ABR. For larger size lesions (2 cm and larger), research is conclusive 
for high ABR sensitivity; however, for smaller size lesions (1 cm and smaller) research 
shows contradictory evidence regarding ABR sensitivity. 
In a study conducted by Schmidt, Sataloff, Newman, Spiegel, and Meyers (2001), 
they reported the sensitivity of ABR testing for different lesion sizes. They found a 
sensitivity of 58% for lesions smaller than 1 centimeter (cm), 94% for lesions 1-1.5 cm, 
and 100% for lesions larger than 1.5 cm. Zappia, O'Connor, Wiet, and Dinces (1997) 
reported sensitivity measures of 89% for lesions smaller than 1 cm, 98% for lesions 1-1.2 
cm, and 100%s for lesions larger than 2 cm. Chandrasekhar, Brackmann, & Devgan 
(1995) reported ABR sensitivity of 83%> for lesions smaller than 1 cm, 100% for tumors 
1-1.5 cm, 86% for lesions 1.6-2 cm, and 100%o for lesions larger than 3 cm. Gordon & 
Cohen (1995) reported sensitivities of 69% for lesions smaller than 9 millimeters (mm.), 
89%> for lesions 1-1.5 cm, 86% for lesions 1.6-2 cm, and 100% for lesions larger than 2 
cm. 
Recommended Protocol for Neurodiagnostic ABR Testing 
Burkard et al. (2007) recommended placing the noninverting electrode on the high 
forehead, the inverting electrode on the ipsilateral mastoid, and the common or ground 
electrode on the lower forehead. They also recommended presenting a click stimulus at a 
level of at least 70 dBnHL. At least 1000-2000 sweeps or averages should be presented. 
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They also recommended setting the bandwidth filter from 100-3000 Hz and 
implementing a 10 ms recording window. 
Katz (2002) recommended placing the noninverting electrode on the forehead, the 
inverting electrode on the ipsilateral mastoid, and the common or ground on the 
contralateral mastoid. He also recommended presenting a click stimulus at a level of .70-
yu aoiiriu ana a raie oi LU-ZU nz . m ieasi iuuu-zuuu sweeps snouia oe pieserueu 
implementing a 10 ms recording window. 
Hall (2006) recommended placing the noninverting electrode on the high 
forehead, the inverting electrode on the ipsilateral earlobe, and the ground on the lower 
forehead. He also recommended presenting a click stimulus at a high level at a rate 
greater than 20/sec to save time and greater than 90/sec to detect retrocochlear 
dvsfunctiorL He also recommended usinp a rarefaction nolaritv at a duration of 0.1 ms. 
The bandwidth of the filter should be set from 30-3000 Hz, implementing a 15 ms 
recording window. The number of sweeps performed is variable, depending on the 
signal-to-noise ratio. 
Establishing Norms 
Generalized norms are available for ABR test results, but it is important for each 
audiologicai clinical facility to develop its own set of standardized norms for each piece 
of testing equipment. Tnis permits quick and easy identification of abnormal responses. 
To establish clinical norms, participant factors, stimulus factors, and recording factors 
must be taken into account. The stimulus and recording parameters must be consistent for 
each participant tested (Weber, 1992). 
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Hood (1998b) recommended conducting at least 5 to 10 ABR's on normal hearing 
participants using the exact same test parameters that are used for neurodiagnostic ABR 
testing at that facility. This ensures the clinician the equipment is working properly and 
test results can be converted into normative data and compared to published norms. This 
also gives the clinician practice using that specific piece of equipment and test 
parameters. 
When establishing norms, a minimum of 10 young adult women and 10 young 
adult men with normal hearing and no prior history of neurologic or otologic disorders 
must be tested (Weber, 1992). Sininger (1992) stated that "adult females have shorter 
peak latencies, larger amplitudes, and shorter interpeak intervals than males. It is 
recommended that separate norms be established for men and women" (p. 16). 
During the development of clinical norms, means need to be determined for the 
absolute latencies of waveforms I, III, and V, as well as the I-III, III-V, and I-V IPL 
values. Additionally, standard deviations (SD) must be developed to determine normal 
from abnormal responses. A +/- 2 SD and/or +/- 2.5 SD range is commonly used to 
differentiate between normal latency values and abnormal latency values. 
Statement of the Problem 
The Louisiana Tech University Speech and Hearing Center (LTSHC) is currently 
implementing ABR testing using published normative data for comparisons. Instrument 
specific normative data has not been determined for the Nicolet Testing System. 
Normative date has also not been determined for the local population. This study is 
important because it provides normative data for this specific testing system which allows 
for a quick and easy reference for comparing ABR results. This study also provides a set 
protocol for identifying retrocochlear pathologies in adult clients who are tested at the 
LTSHC. 
CHAPTER II 
METHODS AND PROCEDURES 
Participants 
Twenty participants, ten males and ten females, between the ages of 18-35 years 
were selected from the student population of Louisiana Tech University to participate in 
this study. Each participant signed an informed consent form (see Appendix A) and 
completed a demographic information form (see Appendix B), which consists of their 
age, outer and middle ear status, and hearing screening results. 
Experimental Procedure 
An otoscopic examination was completed bilaterally on each participant with a 
Welch Allen otoscope. If otoscopy revealed an abnormal ear canal, tympanic membrane, 
or excessive cerumen the participant was used in this study and appropriate 
recommendations were made. 
Tympanometry, a test of middle ear function, was performed bilaterally using a 
Grason-Stadler (GSI) TympStar Middle-Ear Analyzer, which is available at the Louisiana 
Tech Speech and Hearing Center (LTSHC). Normal (Type A) tympanometric tracings are 
consistent with normal middle ear function. Type A tracings consist of an ear canal 
volume (ECV) of 0.5 cc-2.0 cc, static compliance of 0.3 ml.-1.7 ml., and peak pressure 
of-100 daPa- +100 daPa. If tympanometry results did not meet these criteria, the 
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participant was not used in this study. Additionally, if an abnormality of the middle ear 
system was diagnosed the appropriate recommendations were made. 
Following otoscopy and tympanometry, a pure-tone hearing screening was 
administered to each ear. Pure-tone testing was performed using a GSI 61 clinical 
audiometer, which is available at the LTSHC. Air conduction tones (pulsed, pure tones) 
were presented through insert earphones (Etvmotic Research 3-14A) at all octave 
frequencies from 250-8000 Hz at 15 dB hearing level (HL). If a participant had a 
threshold greater than 15 dB HL at any of the octave frequencies tested, they were not 
used in this study. Additionally, if a participant had thresholds greater than 15 dB HL a 
full audiological evaluation was completed and appropriate recommendations were made 
if a hearing loss or abnormalities were present. 
Auditory Brainstem Response (ABR) testing was performed with the Nicolet 
Testing System, which is available at the LTSHC. Each participant was given a 
description of the testing and all electrode sites were cleaned. Each of the four electrode 
sites were cleaned thoroughly with an abrasive scrub and alcohol. This was done to 
ensure that the skin was exfoliated so that the electrodes made contact with the skin and 
reduced the impedance of the electrical signal. The electrodes were then applied, which 
consisted of a vertical, two channel, four electrode montage. Disposable surface 
electrodes (Kendall Soft-E H69P Repositionable Monitoring Electrodes) were used. The 
inverting (negative) electrodes were placed on the right (A2) and left mastoids (Al). The 
non-inverting (positive) electrode was placed on the high forehead (Fz) and the ground 
electrode was placed on the lower forehead (FPz). Inverting and non-inverting electrodes 
were used to ensure common mode rejection, which increased the likelihood that noise 
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artifact was cancelled, therefore improving the signal-to-noise ratio. The impedance of 
each of the electrodes was checked to ensure each electrode connection was no more than 
5000 ohms and to ensure that the difference between any two electrodes was no greater 
than 2000 ohms. If the impedance criteria were not met, each of the electrode sites were 
examined and the impedance was measured again. 
The participant was then instructed to lie down and to relax their muscles and 
even sleep if possible. The myogenic artifact is lowered the more the muscles are relaxed. 
When the myogenic noise is reduced, the auditory brainstem responses (ABR) are easier 
to obtain and are composed of better overall morphology. 
Testing was performed by presenting broadband clicks through insert earphones 
(EAR Link Foam Eartips connected to the Nicolet Model Tip-300 and Nicolet C-300 
Cable) to each ear separately. The broadband click stimulus activates a larger frequency 
region than tone-bursts and therefore provides a more robust ABR waveform. ABR 
recordings are best obtained at higher intensity levels (70-90 dBnHL) while using slower 
presentation rates. Therefore, the clicks were presented at 80 dBnHL with a stimulus rate 
of 19.1 clicks/sec. At least two repeatable waveforms were obtained for each ear. A 
rarefaction stimulus phase was used for all presentations. A rarefaction stimulus phase 
provides the greatest chance of clearly identifying wave I of the ABR (Hall, 2006). 
Additional presentations were given if the morphology of the waveforms was not 
sufficient enough to label, or the waveforms did not repeat. Artifact rejection was enabled 
during all recordings. Artifact rejection prevents a response with excessive voltage 
(myogenic artifact, noise) to be averaged into the overall recording, thus improving the 
overall signal-to-noise ratio. 
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All presentations consisted of 1500 sweeps, with no more than 149 sweeps being 
rejected through artifact rejection (less then a 10% accepted/rejection rate). If greater than 
a 10% rejection rate occurred on a consistent basis, testing was temporarily stopped and 
the system was checked for high impedance, excessive external electrical interference, or 
excessive myogenic potential. 
The recording time for each presentation was 10 ms this ensuring proper time 
window for all waveforms to be recorded. The stimulus duration was 0.1 ms. Research 
has shown that an ABR is best obtained with, a transient or abrupt stimulus (Hall, 2006). 
The delay time between the stimulus presentation and the recording was 0 ms, meaning 
that each of the recordings started at the end of the stimulus presentation. Band-pass 
filtering was utilized in order to increase the signal-to-noise ratio. A high pass filter 
setting of 100 Hz and a low pass filter setting of 3000 Hz were used for each presentation 
(reference from filter setting section). 
The waveforms were analyzed by the test administrator to determine the absolute 
latency values of waveforms I, III, and V. All waveforms were marked at the peak of the 
waveform to ensure that a consistent marking method was used for each participant. 
Using the absolute latencies, the interpeak latency (IPL) values (Till, III-V, and I-V) 
were obtained. Both absolute latency and IPL calculations were made for each ear. 
Once all data was collected, the absolutes latencies of waveforms I, III and V for 
each of the participants were entered into a Microsoft Excel spreadsheet. For each 
participant there was a total of six entries: the absolute latencies of wave I, III, and V for 
each ear. Following data entry, the average latency values were calculated for waveforms 
37 






The average age of the male group was 25.1 years, ranging from 21-34 years of 
age while the average age of the female group was 24.7 years, ranging from 21-33 years 
of age. The average age of the total population was 24.9 years. 
Male Results 
Absolute Latencies 
The mean wave I latency value for the male group was 1.58 ms with a range of 
0.58 ms (1.38 ms to 1.96 ms). When the two standard deviation value of 0.29 ms is 
applied to the mean of wave I (1.58 ms), the two standard deviation range for wave I 
becomes 1.29 to 1.87 ms. 
The mean wave III latency value for the male group was 3.78 ms with a range of 
0.48 ms (3.54 ms to 4.02 ms). When the two standard deviation value of 0.23 ms is 
applied to the mean of wave III (3.78 ms), the two standard deviation range for wave III 
War> /~\ +-*-» o e * S *s t-r\ A M O rv ^ 
The mean wave V latency value for the male group was 5.53 ms with a range of 
0.66 ms (5.28 ms to 5.94 ms). When the two standard deviation value of 0.35 ms is 
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applied to the mean of wave V (5.53 ms), the two standard deviation range for wave V 
becomes 5.18 to 5.88 ms. 
Interpeak Latencies 
The mean wave I-V interpeak latency value for the male group was 2.20 ms with 
a range of 0.46 ms (1.96 ms to 2.42 ms). When the two standard deviation value of 0.26 
ms is applied to the mean of wave I-V interpeak (2.20 ms), the two standard deviation 
range for wave I-V interpeak becomes 1.94 to 2.46 ms. 
The mean wave III-V interpeak latency value for the male group was 1.74 ms 
with a range of 0.40 ms (1.54 ms to 1.94 ms). When the two standard deviation value of 
0.24 ms is applied to the mean of wave III-V interpeak (1.74 ms), the two standard 
deviation range for wave III-V interpeak becomes 1.34 tol .99 ms. 
The mean wave I-V interpeak latency value for the male group was 3.94 ms with 
a range of 0.64 ms (3.64 ms to 4.28 ms). When the two standard deviation value of 0.38 
ms is applied to the mean of wave I-V interpeak (3.94 ms), the two standard deviation 
range for wave I-V interpeak becomes 3.56 to 4.32 ms. See Table 1 for the male group 
waveform values described below. 
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Table 1 
Means and 95n Percentile Results for Absolute and Interpeak Latencies in the Male 
Group 




























The mean wave I latency value for the female group was 1.60 ms with a range of 
0.28 ms (1.48 ms to 1.76 ms). When the two standard deviation value of 0.15 ms is 
applied to the .mean of wave I (1.60 ms), the two standard deviation range for wave I 
becomes 1.45 to 1.74 ms. 
The mean wave III latency value for the female group was 3.75 ms with a range 
of 0.38 ms (3.60 ms to 3.98 ms). When the two standard deviation value of 0.20 ms is 
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applied to the mean of wave III (3.75 ms), the two standard deviation range for wave III 
becomes 3.55 to 3.95 ms. 
The mean wave V latency value for the female group was 5.40 ms with a range of 
0.68 ms (5.02 ms to 5.70 ms). When the two standard deviation value of 0.41 ms is 
applied to the mean of wave V (5.40 ms), the two standard deviation range for wave V 
becomes 4.99 to 5.81 ms. 
Interpeak Latencies 
The mean wave I-III interpeak latency value for the female group was 2.15 ms 
with a range of 0.30 ms (2.04 ms to 2.34 ms). When the two standard deviation value of 
0.15 ms is applied to the mean of wave I-III interpeak (2.15 ms), the two standard 
deviation range for wave I-III interpeak becomes 2.00 to 2.31 ms. 
The mean wave III-V interpeak latency value for the female group was 1.65 ms 
with a range of 0.74 ms (1.26 ms to 2.00 ms). When the two standard deviation value of 
0.37 ms is applied to the mean of wave III-V interpeak (1.65), the two standard deviation 
range for wave III-V interpeak becomes 1.28 to 2.02 ms. 
The mean wave I-V interpeak latency value for the female group was 3.80 ms 
with a range of 0.70 ms (3.38 ms to 4.08 ms). When the two standard deviation value of 
0.38 ms is applied to the mean of wave I-V interpeak (3.80 ms), the two standard 
deviation range for wave I-V interpeak becomes 4.00 to 4.19 ms. See Table 2 for the 
female (Troun waveform values described below 
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Table 2 
Means and 95" Percentile Results for Absolute and Interpeak Latencies in the Female 
Group
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The mean wave I latency value for all subjects was 1.59 ms with a range of 0.58 
ms (1.38 ms to 1.96 ms). When the two standard deviation value of 0.23 ms is applied to 
the mean of wave I (1.59 ms), the two standard deviation range for wave I becomes 1.36 
to 1.82 ms. Therefore, wave I absolute latencies which are recorded later than 1.82 ms 
will be considered abnormal and ^oncidered ac an indicator of a "o^^sible retrocochlear 
pathology. 
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The mean wave III latency value for all subjects was 3.77 ms with a range of 0.48 
ms. (3.54 ms to 4.02 ms). When the two standard deviation value of 0.22 ms is applied to 
the mean of wave III (3.77 ms), the two standard deviation range for wave III becomes 
3.55 to 3.98 ms. Therefore, wave III absolute latencies which are recorded later than 3.98 
ms will be considered abnormal and considered as an indicator of a possible retrocochlear 
pathology. 
The mean wave V latency value for all subjects was 5.46 ms with a range of 0.92 
ms (5.02 ms to 5.94 ms). When the two standard deviation value of 0.40 ms is applied to 
the mean of wave V (5.46 ms), the two standard deviation range for wave V becomes 
5.06 to 5.86 ms. Therefore, wave V absolute latencies which are recorded later than 5.86 
ms will be considered abnormal and considered as an indicator of a possible retrocochlear 
pathology. 
Interpeak Latencies 
The mean wave I-III interpeak latency value for all subjects was 2.18 ms with a 
range of 0.46 ms (1.96 ms to 2.42 ms). When the two standard deviation value of 0.21 ms 
is applied to the mean of wave I-III interpeak (2.18 ms), the two standard deviation range 
for wave I-III interpeak becomes 1.97 to 2.39 ms. If a I-III interpeak latency exceeds 2.39 
ms it will be considered abnormal and will indicate a possible retrocochlear pathology. 
The mean wave III-V interpeak latency value for all subjects was 1.70 ms with a 
range of 0.74 ms (1.26 ms to 2.00 ms). When the two standard deviation value of 0.32 ms 
is applied to the mean of wave III-V interpeak (1.70 ms), the two standard deviation 
range for wave III-V becomes 1.38 to 2.02 ms. If a III-V interpeak latency exceeds 2.02 
ms it will be considered abnormal and will indicate a possible retrocochlear pathology. 
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The mean wave I-V interpeak latency value for all subjects was 3.87 ms with a 
range of 0.90 ms (3.38 ms to 4.28 ms). When the two standard deviation value of 0.40 ms 
is applied to the mean of wave I-V interpeak (3.87 ms), the two standard deviation range 
for wave I-V becomes 3.47 to 4.27 ms. If a I-V interpeak latency exceeds 4.27 ms it will 
be considered abnormal and will indicate a possible retrocochlear pathology. See table 3 
for the male group waveform values described below. 
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Table 3 
Means and 95" Percentile Results for Absolute and Interpeak Latencies in the Combined 
Group 






























- This study was designed to develop normative data for Auditory Brainstem 
Response (ABR) testing on the Nicolet Testing System. This system is currently being 
implemented for ABR testing at Louisiana Tech University Speech and Hearing Center. 
Publicized norms are available; however, research is conclusive that standardized norms 
should be developed for each testing system and for the local population being tested. 
Instrument specific normative data has not been determined for the Nicolet Testing 
System, nor has it been determined for the local population. This study provides a quick 
and accessible reference guide for determining normal versus abnormal results. It also 
provides a set protocol for identifying retrocochlear pathologies in adult clients who are 
tested at the Louisiana Tech University Speech and Hearing Center. 
Results 
Testing was performed on ten adult males and ten adult females, ranging from 18-
35 years of age with normal middle ear function and normal hearing sensitivity. 
Normative data was developed for the male group, the female group, and for both groups 
combined (see Tables 1-3). 
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waveform I was slightly later for the female group compared to the male group. The 
mean interpeak latencies of all waveforms were slightly later for the male group 
compared to the female group. This is in agreement with research, which states that males 
have later latency values than females*due to average head size differences. 
Published Normative Data 
In a study conducted by Musiek, Josey, & Glasscock (1986), using a 80 dBnHL 
stimulus level and a stimulus rate of 11.3 clicks/sec, they reported mean latency values of 
2.05 ms for the I-IIIIPL, 1.85 ms for the III-V IPL, and 3.88 ms for the I-V IPL. The 
researchers also reported ±2 SD values of 2.3 ms for the I-III IPL, 2.3 ms for the III-V 
IPL, and 4.4 ms for the I-V IPL. Additionally, they reported ±2.5 SD values of 2.40 ms 
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waveform values described below. 
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Table 4 
Mustek, Josey, and Galsscock's Normative Data 
Mean 2SD 
Interpeak Latencies 
I-III 2.05 0.25 
III-V 1,85 0.45 
I-V 3.88 0.52 
Antonelli, Bellotto, and Grandori (1987) developed ABR normative data to 
determine latency and SD values (+2.5 SD values) using a stimulus level of 100 dB 
peSPL and a stimulus rate of 11 clicks/sec. They reported a mean absolute latency of 1.54 
ms with a SD of 1.74 ms for waveform I, 3.73 ms with a SD of 3.98 ms for waveform III, 
and 5.52 ms with a SD of 4.56 ms for waveform V. This study also reported mean latency 
values of 2.19 ms with a SD of 2.64 ms for the I-III IPL, 1.79 ms with a SD of 2.42 ms 
for the III-V IPL, and 3.98 ms with a SD of 4.56 ms for the I-V IPL. See Table 5 for 
waveform values described below. 
49 
Table 5 













I-III 2.19 0.45 
III-V 1.79 0.63 
I-V 3.98 0.58 
Schwartz, Pratt, and Schwartz (1989), conducted a study to determine normative 
data for middle-aged adults using a stimulus level of 80 dBnHL and a click stimulus. This 
study was designed to determine +2.5 SD values. They reported a mean absolute latency 
of 1.54 ms with a SD of 1.79 ms for waveform I, 3.70 ms with a SD of 4.08 ms for 
waveform III, and 5.60 ms with a SD of 6.08 ms for waveform V. This study also 
reported mean latency values of 2.20 ms with a SD of 2.60 ms for the I-III IPL, 1.84 ms 
with a SD of 2.26 ms for the III-V IPL, and 4.04 ms with a SD of 4.49 ms. for the I-V 
IPL. See Table 6 for waveform values described below. 
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Table 6 














III-V 1.84 0.42 
I-V 4.04 0.45 
Joseph, West, Thorton, & Herman (1.987), also conducted a study on ABR 
normative data for normal hearing adults. They reported mean absolute latencies of 1.65 
ms for waveform I, 3.80 ms for waveform III, and 5.64 ms for waveform V. Additionally, 
the reported mean latency values of 2.15 ms for the I-III FPL, 1.84 ms for the III-V IPL, 
and 3.99 ms for the I-V IPL. See Table 7 for waveform values described below. 
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Table 7 










Hall (2006) published normative data for 786 nontumor normal hearing adults. 
He reported mean absolute latencies of 1,65 ms with a 2 SD of 0,28 ms for waveform I, 
3.80 ms with a 2 SD of 0.36 ms for waveform III, and 5.64 ms with a 2 SD of 0.46 ms for 
waveform V. He also reported mean interpeak latency values of 2.15 ms with a 2 SD of 
0,28 ms for the wave I-III, 1.84 ms with a 2 SD of 0,28 ms for wave III-V, and 3.99 ms 








Hall's Normative Data 
Mean SD 99%ile 
Absolute Latencies 
Wave I 1.65 0.14 
Wave III 3.80 0.18 





Hood (1998b) published normative data for nontumor normal hearing females 
between the ages of 20-30 years of age, implementing an 80 dBnHL click. She reported 
mean absolute latencies of 1.62 ms with a 2 SD of 0.24 ms for waveform I. 3.68 ms with 
a 2 SD of 0.16 ms for waveform III, and 5.47 ms with a 2 SD of 0.24 ms for waveform V. 
She also reported mean interpeak latency values of 2.06 ms with a 2 SD of 0.22 ms for 
wave I-III, 1.79 ms with a 2 SD of 0.18 ms for wave HI-V, and 3.85 ms with a 2 SD of 




I-III 2.15 0.14 
III-V 1.84 0.14 
I-V 3.99 0.20 
Table 9 
Hood's Normative Data 













III-V 1.79 0.09 
I-V 3.85 0.14 
The mean data collected for this study compares favorably to the means obtained 
in the normative data studies listed above. This indicates that the data collected is 
appropriate for determining the possible presence of retocochlear pathologies during 
neurodiagnosrtic ABR evaluations. It is again appropriate to note that pathological 
disorders prolong ABR latencies. As a result, the upper latency limit is determined by 
applying +2 or +2.5 standard deviations to the mean value. The lower limit of the applied 
standard deviation range is not used to delineate between a normal auditory system and 
an auditory system with a retrocochlear pathology. Therefore the 95 percentile (+2 SD) 
values obtained for the combined group results will be used as the delineation point. 
APPFIVTMY A 
HUMAN SUBJECTS PERMISSION FORM 
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HUMAN SUBJECTS PERMISSION FORM 
The following is a brief summary of the project in which you have been asked to participate. Please read 
this information before sianiria below: 
TITLE: Auditory Brainstem Response (ABR) Normative Data for the Nicolet Testing System. 
PURPOSE OF STUDY/PROJECT: The purpose of this experiment is to establish normative data for ABR 
testing for the Nicolet Testing System, which is used at the Louisiana Tech University Speech and Hearing 
Center. 
PROCEDURES: Each participant will be asked to have an ABR test conducted on them. The participant 
will be instructed to remain as relaxed as possible and sleep if desired. The testing will be performed by 
presenting a click stimuli at 70 dB nHL and 90 dB nHL to each ear with a stimulus rate of 19.1 
clicks/second. Data will be recorded to determine latency values for waveforms I, III, and V and interpeak 
intervals I-III, III-V, and I-V for each ear. Results will be entered into a Microsoft Excel spreadsheet for 
data analysis. 
INSTRUMENTS: The subject's identity will not be used in any form in the analysis or representation of 
the data. Only numerical data such as latency values of waveforms I, III, and V and interpeak intervals I-
III, III-V, and I-V for each ear will be used in the presentation of the results. 
RISKS/ALTERNATIVE TREATMENTS: There are no known risks to subjects. 
BENEFITS/COMPENSATION: Each participant will receive a free audiological evaluation provided by 
Louisiana Tech Speech and Hearing Center. 
I, , attest with my signature that I have read and understood the above 
description of the study, "Sound pressure levels within the ear canal of iPod users," and its purposes and 
methods. I understand that my participation in this research is strictly voluntary and my participation or 
refusal to participate in this study will not affect my relationship with Louisiana Tech University and/or 
Louisiana Tech Speech and Hearing Center. Furthermore, I understand that I may withdraw from the study 
at any time or refuse to answer any questions without penalty. Upon completion of the study, I understand 
that the results will be freely available to me upon request. I understand that the results will be 
confidential, accessible only to the project director, principal experimenters, myself, or a legally appointed 
representative. I have not been requested to waive nor do I waive any of my rights related to participating 
in this study. 
Signature of Participant Date 
CONTACT INFORMATION: The principal experimenter listed below may be reached to answer 
questions about the research, subject's rights, or related matters. 
Matthew Bryan, Au.D., CCC-A Department of Speech (318) 257-3102 
Sheryl Shoemaker, Ph.D., CCC-A Department of Speech (318) 257-2146 
Members of the Human Use Committee of Louisiana Tech University may also be contacted if a problem 
cannot be discussed with the experimenters: 
Dr. LesGuice (318)257-4647 
Dr. Mary Livingston (318)257-2292 
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